QualityStocksNewsBreaks Archives - Page 182 of 1537

TuesdayMar 18, 2025 8:30 am

QualityStocksNewsBreaks – Capstone Holding Corp. (NASDAQ: CAPS) Launches Linear Brick Line as Instone Product Sales Surge Over 30 Percent

Capstone Holding Corp. (NASDAQ: CAPS), a building products holding company expanding through acquisitions and organic growth, announced the launch of its new 'Linear Brick' line under the Toro Stone brand, following more than 30% year-over-year growth in the thin brick veneer segment at its Instone business. The new product, inspired by Italy’s historic masonry, offers three distinct palettes and targets the fast-growing adhered veneer market, known for its aesthetic, durability, and ease of installation. To view the full press release, visit https://ibn.fm/b8tcx About Capstone Holding Corp. Capstone Holding Corp. is a building products distribution company that has successfully grown its…

MondayMar 17, 2025 9:05 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) to Present at BIO-Europe Spring 2025

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and contract development and manufacturing (CDMO) services, announced its participation in the BIO-Europe Spring 2025 conference from March 17-19 in Milan, Italy. The company’s leadership will meet with potential pharmaceutical partners, prospective CDMO clients, and institutional investors to showcase its innovative NanoAb pipeline and biologics manufacturing capabilities. Scinai will also exhibit its CDMO services at booth #22. To view the full press release, visit https://ibn.fm/YRT22 About Scinai Immunotherapeutics Ltd. Scinai is a biopharmaceutical company with two complementary business units. One is focused on in-house development…

FridayMar 14, 2025 3:55 pm

QualityStocksNewsBreaks – Adageis’ AI-Driven Approach: A Game-Changer in Efficient, Patient-Centered Healthcare

Adageis was featured in a recent article that discussed how its ProActive Care approach shifts healthcare from reactive to preventive, patient-centered care by leveraging AI-driven analytics to identify high-risk patients and address care gaps. This model enhances patient outcomes by focusing on early intervention, care coordination, more time with doctors to focus on patient needs, and better overall health management. For healthcare providers, it boosts operational efficiency and revenue potential through optimizing workflows, meeting value-based care metrics, and minimizing administrative burdens. With the ability to integrate seamlessly with major electronic health record (“EHR”) systems, Adageis’ platform supports providers in delivering more…

FridayMar 14, 2025 3:35 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) Novel Therapies Show Promise Against Aggressive Cancers

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company that is pioneering proprietary technology designed to attack solid tumors, empowering the immune system to combat cancer. The company was featured in a recent article that discussed its platform, which utilizes antitumor virotherapies that selectively infect and kill cancer cells while stimulating the body’s immune response. Calidi’s pipeline includes three key therapies — RTNova, SuperNova and NeuroNova — that incorporate advanced technologies such as stem cells and antitumor viruses to target and destroy cancer cells. Calidi Biotherapeutics’ innovative therapies hold the potential to revolutionize cancer treatment by enhancing efficacy and stimulating…

FridayMar 14, 2025 1:05 pm

QualityStocksNewsBreaks – Fifty 1 Labs Inc. (FITY) Achieves Key Milestone in Solidifying Brand, Moves Toward Regaining 15c211 Compliance

Fifty 1 Labs (OTC: FITY), formerly Consumer Automotive Finance Inc. (OTC: CAFI), has successfully completed its name and ticker symbol change, now officially trading as FITY on the OTC market. This marks a significant milestone as the company continues executing its strategic growth initiatives. In addition, the company has responded to a second round of comments in its ongoing efforts to regain compliance with SEC Rule 15c2-11. "We are excited about the progress we've made in solidifying our brand identity and strengthening our market position," said Brandon Spikes, CEO of Fifty 1 Labs. "Finalizing our name and symbol change represents…

FridayMar 14, 2025 9:00 am

QualityStocksNewsBreaks – Nicola Mining Inc. (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) Secures Final Permit for Bulk Sampling at Dominion Creek, Closes $1.13M Financing

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) has received the Final Permit to conduct a bulk sample at its Dominion Creek Mineral Project, a high-grade gold and silver property in which the company holds a 75% economic interest. The permit, effective until Feb. 27, 2030, allows Nicola and partner High Range Exploration Ltd. to extract ore before transitioning to reclamation. The company also obtained a Free Use Permit to upgrade a haul road for ore transport. Additionally, Nicola closed a non-brokered private placement, issuing 4,038,955 units for gross proceeds of approximately $1.13 million, with net proceeds of $1.07 million…

FridayMar 14, 2025 8:30 am

QualityStocksNewsBreaks – D-Wave Reports Fourth Quarter and Year-End 2024 Results

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has announced its financial results for fourth quarter and year-end 2024, with a 128% year-over-year increase in bookings, reaching $23.9 million in bookings for the year ended December 31, 2024. The company also announced a consolidated cash balance that now exceeds $300 million. "Every day D-Wave’s quantum technology is helping customers gain competitive advantages, discover new scientific breakthroughs, and fuel innovations that were previously unimaginable," said Dr. Alan Baratz, CEO of D-Wave. "Our mission is unwavering - to help organizations realize the benefits of quantum…

ThursdayMar 13, 2025 2:35 pm

QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Poised for Growth Amid Potential 2X Price Surge

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is set to benefit from a projected rise in palladium prices, which one industry analyst predicts could double over the next decade. The expected surge is attributed to several key factors including supply constraints, high demand from the automotive industry, as well as limited substitution options. As an emerging player in the palladium sector, PLG is strengthening its position by advancing the Waterberg Project in South Africa, which is set to be one of the world’s largest and lowest-cost underground platinum group metal (“PGM”) mines. The company has explored opportunities to enhance its…

ThursdayMar 13, 2025 9:55 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Releases Report on Multi-Team Ownership in Women’s Soccer

Brera Holdings (NASDAQ: BREA) an Ireland-based international sports holding company, has published a special report, BREAKAWAY: How Multi-Team Ownership May Reshape Women’s Soccer, co-authored with Clifford Chance LLP. The report explores the growing application of the multi-club ownership ("MCO") model in women’s soccer, highlighting its strategic benefits, regulatory considerations, and commercial opportunities. Brera has expanded its investment in women’s sports with ownership stakes in soccer and professional volleyball clubs across multiple markets, reinforcing its commitment to the sector's long-term growth. To view the full press release, visit https://ibn.fm/MAig5 About Brera Holdings PLC Brera Holdings PLC is focused on expanding its…

ThursdayMar 13, 2025 9:25 am

QualityStocksNewsBreaks – Bioadaptives Inc (BDPT) Completes Successful Dosage Trials for Zeranovia™ Weight Loss Product

Bioadaptives (BDPT) announced the successful completion of dosage trials for Zeranovia™, its innovative weight loss product. Participants in the trial reported consistent weight loss of 5 to 7 pounds per week with minimal side effects, primarily mild gastrointestinal discomfort that was managed through dosage adjustments. With high participant satisfaction and all subjects eager to continue, BioAdaptives plans to refine dosing for the next phase of clinical trials, reinforcing its commitment to providing effective weight management solutions. To view the full press release, visit https://ibn.fm/Ho0gx About BioAdaptives, Inc. BioAdaptives, Inc. (OTC: BDPT) is a leading innovator in the health and wellness…

Site Search

Company Search

Category: QualityStocksNewsBreaks